Phase 2b Study of GSK4532990 in Adults With NASH

NCT05583344 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

284

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonalcoholic Fatty Liver Disease
Non-alcoholic Fatty Liver Disease

Interventions

DRUG: GSK4532990
DRUG: Placebo

Sponsor

GlaxoSmithKline